Breaking News
Sort by:
Top Post
One Million Checks Delivered By NHS ‘One Stop Shops’
NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]
New £12.7M Centre of Excellence in Emerging Digital Technologies Officially Opens
The University of Liverpool’s Digital Innovation Facility (DIF), a £12.7 million Centre of Excellence in […]
Babylon GP At Hand Opens Two News Clinics For London Patients
Babylon GP at Hand has opened two new clinics situated in London that will provide […]
Minnesota Neurosurgeon Among First in Country to Perform Navigated Spine Fusions With Inspired Spine OLLIF Technology | Pharmtech Focus
Dr. Uzma Samadani, A Minneapolis neurosurgeon renowned for spine tumor resection and complex neurotrauma repair has completed 4 […]
Arrayjet Introduces Mercury Range of Next-generation Microarray Printers
Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of […]
Evonetix Granted Patent for Technology Enabling Thermally-controlled DNA Synthesis
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]
Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist
French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]
NHS Announces £127m Maternity Boost for Patients and Families
The NHS in England has today announced a £127 million funding boost for maternity services across […]
TendoNova wins FDA Clearance for Its New Microinvasive Ocelot Surgical Tool
TendoNova, an emerging leader in microinvasive sports medicine procedures, is pleased to announce the FDA […]
Seabelife Receives Close to €1.4m Deep Tech Financing from Bpifrance
SeaBeLife, a biotech company developing drug candidates intended to block cell necrosis, today announces that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more